Overview
Melpomeni Fani practices in Basel, Switzerland. Fani is rated as an Elite expert by MediFind in the treatment of Insulinoma. Their top areas of expertise are Insulinoma, Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1, and Pancreatic Cancer.
Their clinical research consists of co-authoring 68 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 9 articles in the study of Insulinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- InsulinomaFani isElite. Learn about Insulinoma.
- Distinguished
- Neuroendocrine TumorFani isDistinguished. Learn about Neuroendocrine Tumor.
- Advanced
- Low Blood SugarFani isAdvanced. Learn about Low Blood Sugar.
- Multiple Endocrine Neoplasia
- Multiple Endocrine Neoplasia Type 1
- Pancreatic CancerFani isAdvanced. Learn about Pancreatic Cancer.
- Experienced
- Congenital HyperinsulinismFani isExperienced. Learn about Congenital Hyperinsulinism.
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
- Medullary Thyroid CarcinomaFani isExperienced. Learn about Medullary Thyroid Carcinoma.
- Prostate CancerFani isExperienced. Learn about Prostate Cancer.
- Thyroid CancerFani isExperienced. Learn about Thyroid Cancer.